FDA Approves Three New Treatments for Hereditary Angioedema in 2025
Hereditary angioedema (HAE), a rare genetic condition characterized by recurrent and unpredictable swelling attacks, is receiving unprecedented attention in 2025 due to the rapid approval of three new treatments by…